Search

Howard V. Owens Jr.

Examiner (ID: 6061)

Most Active Art Unit
1623
Art Unit(s)
1623
Total Applications
421
Issued Applications
221
Pending Applications
107
Abandoned Applications
92

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6921762 [patent_doc_number] => 20010029247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'USE OF A- ALKYLGLUCOSIDES AND A-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS' [patent_app_type] => new [patent_app_number] => 09/197798 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3091 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029247.pdf [firstpage_image] =>[orig_patent_app_number] => 09197798 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/197798
Use of -alkylglucosides and -alkylglucoside esters as anti-microbial an agents Nov 22, 1998 Issued
09/196206 METHOD OF INHIBITING NEOPLASTIC CELLS WITH IMIDAZOQUINAZOLINE DERIVATIVES Nov 19, 1998 Abandoned
09/192493 PHARMACEUTICAL COMPOSITIONS BASED ON DICLOFENAC Nov 16, 1998 Abandoned
Array ( [id] => 4028163 [patent_doc_number] => 05902801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Glucosamine sulfate metal chloride compositions and process of preparing same' [patent_app_type] => 1 [patent_app_number] => 9/191169 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3513 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902801.pdf [firstpage_image] =>[orig_patent_app_number] => 191169 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/191169
Glucosamine sulfate metal chloride compositions and process of preparing same Nov 12, 1998 Issued
Array ( [id] => 4358878 [patent_doc_number] => 06174886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Antipsychotic use of triazolo-pyridazine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/191304 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11136 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174886.pdf [firstpage_image] =>[orig_patent_app_number] => 191304 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/191304
Antipsychotic use of triazolo-pyridazine derivatives Nov 11, 1998 Issued
Array ( [id] => 4411969 [patent_doc_number] => 06265570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Cold water soluble starch aldehydes and the method of preparation thereof' [patent_app_type] => 1 [patent_app_number] => 9/186503 [patent_app_country] => US [patent_app_date] => 1998-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4287 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265570.pdf [firstpage_image] =>[orig_patent_app_number] => 186503 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/186503
Cold water soluble starch aldehydes and the method of preparation thereof Nov 4, 1998 Issued
Array ( [id] => 1447006 [patent_doc_number] => 06369109 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor' [patent_app_type] => B1 [patent_app_number] => 09/182588 [patent_app_country] => US [patent_app_date] => 1998-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 48 [patent_no_of_words] => 31324 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369109.pdf [firstpage_image] =>[orig_patent_app_number] => 09182588 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/182588
Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor Oct 27, 1998 Issued
09/147095 PROCESS FOR THE PREPARATION OF IVERMECTIN Oct 26, 1998 Abandoned
Array ( [id] => 4188046 [patent_doc_number] => 06160128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Tritioacetylating reagents and processes for preparation thereof' [patent_app_type] => 1 [patent_app_number] => 9/177882 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10564 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/160/06160128.pdf [firstpage_image] =>[orig_patent_app_number] => 177882 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/177882
Tritioacetylating reagents and processes for preparation thereof Oct 22, 1998 Issued
Array ( [id] => 4327572 [patent_doc_number] => 06329422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Compositions and methods for cystic fibrosis therapy' [patent_app_type] => 1 [patent_app_number] => 9/174077 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 16175 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329422.pdf [firstpage_image] =>[orig_patent_app_number] => 174077 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/174077
Compositions and methods for cystic fibrosis therapy Oct 15, 1998 Issued
09/172685 CALPAIN INHIBITORS AND THEIR APPLICATIONS Oct 14, 1998 Abandoned
09/169678 METHOD OF INHIBITING NEOPLASTIC CELLS WITH TETRACYCLIC PYRIOD(3,4-B)INDOLE DERIVATIVES Oct 8, 1998 Abandoned
Array ( [id] => 1507796 [patent_doc_number] => 06440947 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method for treating occlusive peripheral vascular disease and coronary disease' [patent_app_type] => B1 [patent_app_number] => 09/167816 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10081 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440947.pdf [firstpage_image] =>[orig_patent_app_number] => 09167816 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/167816
Method for treating occlusive peripheral vascular disease and coronary disease Oct 6, 1998 Issued
09/167634 COMPOSITIONS AND METHODS OF INHIBITING NEOPLASTIC DISEASES WITH COMPOUNDS RELATED TO LIMOCITRIN AND 5-DESMETHYL SINENSETIN Oct 5, 1998 Abandoned
Array ( [id] => 7631179 [patent_doc_number] => 06635753 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof' [patent_app_type] => B1 [patent_app_number] => 09/163321 [patent_app_country] => US [patent_app_date] => 1998-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3478 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635753.pdf [firstpage_image] =>[orig_patent_app_number] => 09163321 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/163321
Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof Sep 29, 1998 Issued
Array ( [id] => 1528745 [patent_doc_number] => 06479657 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Crystalline 1-kestose and process for preparing the same' [patent_app_type] => B1 [patent_app_number] => 09/091182 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13322 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479657.pdf [firstpage_image] =>[orig_patent_app_number] => 09091182 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/091182
Crystalline 1-kestose and process for preparing the same Sep 28, 1998 Issued
09/117115 CONCENTRATED INJECTION AND INFUSION SOLUTIONS FOR INTRAVENOUS ADMINISTRATION Sep 21, 1998 Abandoned
Array ( [id] => 4184005 [patent_doc_number] => 06150337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes' [patent_app_type] => 1 [patent_app_number] => 9/156646 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4835 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150337.pdf [firstpage_image] =>[orig_patent_app_number] => 156646 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/156646
Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes Sep 17, 1998 Issued
Array ( [id] => 1575772 [patent_doc_number] => 06469161 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Chemical fluidification process and conversion process of starchy materials, and new cationic starchy materials' [patent_app_type] => B1 [patent_app_number] => 09/150680 [patent_app_country] => US [patent_app_date] => 1998-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6660 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469161.pdf [firstpage_image] =>[orig_patent_app_number] => 09150680 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/150680
Chemical fluidification process and conversion process of starchy materials, and new cationic starchy materials Sep 9, 1998 Issued
Array ( [id] => 1565342 [patent_doc_number] => 06339073 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases' [patent_app_type] => B1 [patent_app_number] => 09/149998 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4311 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339073.pdf [firstpage_image] =>[orig_patent_app_number] => 09149998 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/149998
Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases Sep 8, 1998 Issued
Menu